Atlas Trials

Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage

Clinical trial NCT04509323 · UNKNOWN

Trial details

NCT number
NCT04509323
Sponsor
Jiangsu Famous Medical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Neurosensory Disorder
Start date
2020-08-03
Primary completion
2021-02-28
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.